Status:
COMPLETED
ToT and Estrogen in Postmenopausal Females
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Stress Urinary Incontinence
Postmenopausal Disorder
Eligibility:
FEMALE
49-65 years
Phase:
PHASE2
PHASE3
Brief Summary
To compare the subjective and objective outcomes of TVT-O procedure alone versus the same procedure followed by the use of premarin vaginal cream for 3 months in postmenopausal female with genuine str...
Detailed Description
a randomized controlled trial comparing the effect of using local estrogen cream after tot in postmenopausal female
Eligibility Criteria
Inclusion
- menopause patients included in group A should have: no history of breast cancer, ovarian cancer or uterine cancer No history of blood clots or thromboembolism No history of heart disease or stroke No history liver disease. Endometrial thickness less than 5mm Have a normal mammogram
Exclusion
- presence of urge or mixed incontinence .
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03295487
Start Date
March 1 2017
End Date
November 30 2020
Last Update
October 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainiy Hospital
Cairo, Egypt, 11562